We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Real-World Evidence About Potential Psychosocial Harms of Lung Cancer Screening

Renda Soylemez Wiener, MD, MPH1,2; Christopher G. Slatore, MD, MSc3,4
[+] Author Affiliations
1The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts
2Center for Healthcare Organization & Implementation Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts
3Health Services Research & Development, Portland VA Medical Center, Portland, Oregon
4Division of Pulmonary & Critical Care Medicine, Oregon Health & Science University, Portland
JAMA Intern Med. 2014;174(8):1416. doi:10.1001/jamainternmed.2014.1643.
Text Size: A A A
Published online


To the Editor We applaud Harris and colleagues1 for their clearly organized taxonomy of potential harms associated with low-dose computed tomographic screening for lung cancer, which includes “psychological harms” as 1 of 4 categories. The authors point out that patients undergoing surveillance for a screening-detected indeterminate nodule are exposed to a prolonged state of uncertainty but comment that there is limited evidence about the associated psychological harms.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





August 1, 2014
Russell P. Harris, MD, MPH; Stacey L. Sheridan, MD, MPH; Carmen L. Lewis, MD, MPH
1Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill
2Division of General Medicine and Epidemiology, University of North Carolina at Chapel Hill
3Division of General Medicine and Clinical Epidemiology, Department of Medicine, University of North Carolina at Chapel Hill
JAMA Intern Med. 2014;174(8):1416-1417. doi:10.1001/jamainternmed.2014.1636.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...